Halozyme Therapeutics
HALO
$32.49
Share price
0.19%
Change (1 day)
-28.44%
Change (1 year)
Categories
Halozyme Therapeutics (HALO) - Net assets
Net assets on the balance sheet as of December 2022 : $0.16 B
According to Halozyme Therapeutics's latest financial reports the company has $0.16 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Halozyme Therapeutics - Net assets on balance sheet (from 2002 to 2022)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.16 B | -13.79% |
| 2021-12-31 | $0.19 B | 30.39% |
| 2020-12-31 | $0.15 B | 64.6% |
| 2019-12-31 | $91.76 M | -63.13% |
| 2018-12-31 | $0.24 B | 19.45% |
| 2017-12-31 | $0.20 B | -741.5% |
| 2016-12-31 | $-32.49 M | -175.54% |
| 2015-12-31 | $42.99 M | 3.98% |
| 2014-12-31 | $41.35 M | -306.86% |
| 2013-12-31 | $-20 M | -140.92% |
| 2012-12-31 | $48.85 M | 348.19% |
| 2011-12-31 | $10.9 M | -46.44% |
| 2010-12-31 | $20.35 M | 194.8% |
| 2009-12-31 | $6.9 M | -55.11% |
| 2008-12-31 | $15.37 M | -73.38% |
| 2007-12-31 | $57.76 M | 150.28% |
| 2006-12-31 | $23.08 M | 26.77% |
| 2005-12-31 | $18.2 M | 22.82% |
| 2004-12-31 | $14.82 M | 147199.86% |
| 2003-12-31 | $0.01 M | -88.41% |
| 2002-12-31 | $0.08 M | 280.13% |
| 2001-12-31 | $0.02 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $76.80 B | 45,132.57% | 🇺🇸 USA |
 Pfizer PFE | $95.91 B | 56,388.30% | 🇺🇸 USA |
 Eli Lilly LLY | $11.29 B | 6,551.96% | 🇺🇸 USA |
 Sanofi SNY | $80.48 B | 47,300.91% | 🇫🇷 France |
 Baxter BAX | $5.94 B | 3,398.86% | 🇺🇸 USA |
 MannKind Corp MNKD | -$0.26 B | -247.55% | 🇺🇸 USA |